Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-28 Sale |
2023-04-06 1:08 pm |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
239 | $0.481 | $115 | 6,612 (Direct) |
View |
| 2023-02-22 Sale |
2023-03-09 4:00 pm |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
537 | $0.65 | $349 | 3,508 (Direct) |
View |
| 2023-02-22 Sale |
2023-03-09 4:00 pm |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
2,693 | $0.62442 | $1,682 | 18,182 (Direct) |
View |
| 2023-02-22 Sale |
2023-03-09 4:00 pm |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
3,730 | $0.6245 | $2,329 | 17,431 (Direct) |
View |
| 2023-02-22 Sale |
2023-03-09 4:00 pm |
T2 Biosystems Inc. | TTOO | Sperzel John J III Chairman and CEO |
9,773 | $0.63221 | $6,179 | 55,996 (Direct) |
View |
| 2022-11-10 Sale |
2022-11-22 4:00 pm |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
1,292 | $1.793 | $2,317 | 8,920 (Direct) |
View |
| 2022-04-07 Purchase |
2022-04-11 10:07 am |
T2 Biosystems Inc. | TTOO | Sperzel John J III Chairman, CEO, and President |
30,000 | $0.5 | $15,000 | 221,773 (Direct) |
View |
| 2022-04-08 Purchase |
2022-04-11 09:55 am |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
12,952 | $0.5 | $6,476 | 181,945 (Direct) |
View |
| 2022-04-07 Purchase |
2022-04-11 09:50 am |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
10,000 | $0.49 | $4,900 | 166,651 (Direct) |
View |
| 2022-04-08 Purchase |
2022-04-11 09:40 am |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
10,000 | $0.4767 | $4,767 | 152,350 (Direct) |
View |
| 2022-04-08 Purchase |
2022-04-11 09:38 am |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
10,600 | $0.489 | $5,183 | 10,600 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-01 Exercise |
2023-08-16 4:01 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
2,004 | $0 | 5,022 (Direct) |
View |
| 2023-01-01 Exercise |
2023-08-16 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
2,004 | $0 | 5,022 (Direct) |
View |
| 2023-08-06 Exercise |
2023-08-16 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
454 | $0 | 3,472 (Direct) |
View |
| 2023-07-03 Option Award(A) |
2023-07-14 6:57 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. CRG Partners III - Parallel Fund B (Cayman) L.P. 10% Owner |
93,298 | $0 | 93,298 (Indirect) |
View |
| 2023-07-03 Option Award |
2023-07-06 6:44 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CR Group L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. CRG Partners III (Cayman) Lev AIV I L.P. 10% Owner |
48,345,798 | $0 | 13,105,006 (Indirect) |
View |
| 2023-03-24 Exercise(A) |
2023-04-05 2:30 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
334 | $0 | 6,851 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-28 4:02 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
333 | $0 | 6,850 (Direct) |
View |
| 2022-10-18 Exercise |
2023-03-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Adams Laura Lee Director |
732 | $0 | 2,196 (Direct) |
View |
| 2023-02-20 Exercise |
2023-03-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
1,333 | $0 | 3,508 (Direct) |
View |
| 2023-02-20 Exercise |
2023-03-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
6,914 | $0 | 18,182 (Direct) |
View |
| 2023-02-20 Exercise |
2023-03-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
6,914 | $0 | 17,431 (Direct) |
View |
| 2023-02-20 Exercise |
2023-03-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sperzel John J III Chairman and CEO |
29,334 | $0 | 55,996 (Direct) |
View |
| 2022-11-08 Exercise |
2022-11-22 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
3,333 | $0 | 8,920 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Elsbree David B Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Adams Laura Lee Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-08-06 Exercise |
2022-08-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
22,727 | $0 | 173,663 (Direct) |
View |
| 2022-08-06 Exercise |
2022-08-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
22,727 | $0 | 173,663 (Direct) |
View |
| 2022-08-06 Exercise |
2022-08-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
22,727 | $0 | 173,663 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:27 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
73,224 | $0 | 128,209 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:27 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
73,224 | $0 | 128,209 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:25 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
73,224 | $0 | 235,121 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:25 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Elsbree David B Director |
73,224 | $0 | 286,205 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:24 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director |
81,967 | $0 | 132,819 (Direct) |
View |
| 2022-06-25 Exercise |
2022-06-28 5:22 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
73,224 | $0 | 128,209 (Direct) |
View |
| 2022-02-26 Option Award |
2022-03-30 4:05 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-30 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
11,428 | $0.364 | 190,660 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-30 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
21,666 | $0 | 190,660 (Direct) |
View |
| 2022-02-24 Exercise(A) |
2022-03-29 4:23 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
145,719 | $0 | 433,789 (Direct) |
View |
| 2022-02-24 Tax Withholding(A) |
2022-03-29 4:23 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
55,008 | $0.4488 | 433,789 (Direct) |
View |